age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
66.66895
|
female
| 1
| 164
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 922,581
| null | null | 37.75
|
asian
| 29.699219
| 32
| 0.702881
| 0.613892
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 162
| 112
| 19.5
| 150
| 19
| 40.19531
| 177.5
| 2.599609
| 4.099609
| 0.899902
| 148
| 7.489258
| null | null | null | null | null |
Coma or Intub
| 2.265625
| 164
| 1
|
73.36597
|
male
| 1
| 64
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 41
| 536,925
| 268,835.5
| null | 44.5
|
white
| 34.5
| 68
| 0.283997
| 0.174988
| 4
| 1
| 0
|
no
| null | null |
dnr after sadm
| 64
| 65
| 21.199219
| 140
| 14
| 36.5
| 164
| 2
| 4.799805
| 2.399902
| 144
| 7.379883
| null | null | null | null | null | null | 3.11377
| 64
| 1
|
37.59299
|
male
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 29,615
| 15,255.3672
| null | 10
| null | 20.898438
| 20
| 0.893921
| 0.855957
| 3
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 5
| 103
| 7.299805
| 120
| 28
| 36.5
| 380
| null | null | 0.799927
| 139
| 7.429688
| null | null | null | null | null | null | 2.90332
| 391
| 1
|
61.34399
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| 11
| null | 9
| 30,431
| 16,560.6875
| null | 26
|
hispanic
| 6.099609
| 24
| 0.912964
| 0.797974
| 1
| 1
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 9
| 140
| 9.798828
| 70
| 26
| 37.5
| 380
| 3.199707
| 0.899902
| 0.899902
| 140
| 7.379883
| null | null | null | 1
| null |
no(M2 and SIP pres)
| 1.1669
| 643
| 1
|
65.92499
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 6,228
| 3,760.6777
| null | 9
|
asian
| 8.599609
| 20
| 0.901978
| 0.773926
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 7
| 73
| 5.099609
| 82
| 16
| 37.79688
| null | 3.799805
| 0.399963
| 1
| 137
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 275
| 1
|
47.33197
|
female
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 35,296
| 15,546.6953
| null | 10.5
|
white
| 31
| 52
| 0.823975
| 0.713989
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 8
| 73
| 12.099609
| 140
| 36
| 36.19531
| 185.6875
| null | null | 0.399963
| 133
| 7.339844
| null | null | null | null | null | null | 4.038086
| 1,783
| 0
|
32.18298
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 12,924
| 7,960.1914
| null | 10.5
|
white
| 19.796875
| 23
| 0.931885
| 0.883911
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 82
| 12.199219
| 80
| 28
| 36
| 242.84375
| null | null | 1.399902
| 134
| 7.519531
| null | null | null | null | null |
<2 mo. follow-up
| 2.862305
| 16
| 1
|
48.04398
|
male
| 1
| 49
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 26
| 786,088
| 421,848.5
| null | 47.5
|
white
| 36.398438
| 61
| 0.464966
| 0.345947
| 6
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 47
| 107
| 21.5
| 150
| 30
| 37.79688
| 138
| 2.699707
| 16.898438
| 1.399902
| 143
| 7.469727
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 49
| 1
|
71.66296
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| null | null | 55
| 21,598
| null | null | 18
|
white
| 24.597656
| 16
| 0.349976
| 0.276978
| 1
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 5
| 113
| 10.199219
| 110
| 20
| 39.89844
| 215.53125
| null | null | 0.899902
| 127
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.276856
| 5
| 1
|
64.45197
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 30,265
| 16,595.1406
| null | 24
|
white
| 50.898438
| 52
| 0.163971
| 0.042999
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 4
| 45
| 16.898438
| 135
| 36
| 37.39844
| 108.15625
| 3
| 1.299805
| 1.699951
| 126
| 7.549805
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 59
| 1
|
24.515
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 83,772
| 45,348.7812
| null | 23.666656
|
hispanic
| 30
| 38
| 0.810913
| 0.747925
| 9
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 19
| 120
| 5.699219
| 110
| 28
| 37.5
| 69
| null | null | 0.899902
| 140
| 7.5
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,782
| 0
|
74.034
|
female
| 1
| 9
|
Colon Cancer
|
Cancer
| 1
| null | null | 9
| 6,429
| 4,587.7227
| null | 7
|
white
| 28
| 25
| 0.536987
| 0.213989
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 73
| 18.398438
| 104
| 24
| 36.19531
| null | null | 3.299805
| 0.699951
| 127
| null | null | null | null | null | null |
<2 mo. follow-up
| 3.373535
| 9
| 1
|
72.03296
|
male
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 94
| 61,750
| 30,964.6875
| null | 25
|
white
| 31.796875
| 39
| 0.169983
| 0.085999
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 11
| 117
| 15.398438
| 120
| 12
| 37.59375
| 60
| 3
| 0.299988
| 1.699951
| 138
| 7.319336
| null | null | null | null | null |
<2 mo. follow-up
| 3.808106
| 14
| 1
|
68.60797
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 8,303
| 5,529.5977
| null | 10
|
white
| 16.796875
| 18
| 0.882935
| 0.804932
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 7
| 87
| null | 80
| 24
| 36.5
| 332
| null | null | 1.799805
| 142
| 7.479492
| null | null | null | null | null | null | 2.932129
| 267
| 1
|
59.40598
|
male
| 0
| 46
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 157,585
| 111,605.25
| null | 12.25
|
asian
| 14.5
| 19
| 0.894897
| 0.823975
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 46
| 78
| 7.199219
| 80
| 24
| 37
| null | null | 0.5
| 1
| 132
| null | null | null | null | 3
| 1
|
no(M2 and SIP pres)
| 1
| 1,278
| 1
|
20.312
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
| null | 0
| 99,728
| 51,038.1562
| null | 45.5
|
white
| 36.195313
| 72
| 0.743896
| 0.662964
| 5
| 0
| 0
|
no
| 0.02
| 0.02
|
no dnr
| 7
| 117
| 6.299805
| 160
| 26
| 40.09375
| 130
| 2.899902
| 2.5
| 3
| 141
| 7.439453
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 7
| 1
|
80.19397
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 61
| 29,857
| 15,619.8047
| null | 17
|
white
| 16.699219
| 25
| 0.682983
| 0.589966
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 98
| 11.099609
| 90
| 32
| 38.5
| 355.5
| null | null | 1.199951
| 141
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.948731
| 10
| 1
|
42.06699
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
$11-$25k
| 0
| 137,943
| 71,544.75
| null | 44
|
white
| 46
| 78
| 0.067993
| 0.023998
| 21
| 0
| 0
|
yes
| null | null |
no dnr
| 4
| 47
| 2.599609
| 175
| 36
| 39.29688
| 244.875
| 3
| 4.799805
| 5.399414
| 135
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.229492
| 4
| 1
|
23.81699
|
male
| 0
| 73
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$25-$50k
| 0
| 245,347
| 129,712.875
| null | 15
|
black
| 33.898438
| 55
| 0.310974
| 0.197998
| 25
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 3
| 127
| 17
| 140
| 28
| 37.89844
| 53.32812
| null | null | 1.399902
| 135
| 7.429688
| null | null | null | 0
| 2
|
adl>=4 (>=5 if sur)
| 2
| 144
| 1
|
65.97095
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 16,273
| 9,118.7188
| null | 23
|
white
| 21.199219
| 37
| 0.807983
| 0.688965
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 6
| 52
| 8.898438
| 80
| 32
| 36.39844
| 247.59375
| 3.599609
| 1.799805
| 1.199951
| 136
| 7.479492
| null | null | null | null | null | null | 2.404785
| 676
| 1
|
67.00098
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 15,242
| 8,664.9688
| null | 12
|
white
| 24.597656
| 31
| 0.796997
| 0.67395
| 1
| 0
| 0
|
no
| 0.75
| 0.6
|
no dnr
| 5
| 42
| 7.799805
| 85
| 20
| 36.89844
| null | 3.599609
| 0.199982
| 1.399902
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.139648
| 11
| 1
|
58.09698
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 0
| 150,445
| 80,889.1875
| null | 31.333328
|
hispanic
| 22.699219
| 38
| 0.844971
| 0.791992
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 21
| 57
| 16.597656
| 120
| 10
| 38.29688
| 192
| 3.199707
| 0.5
| 1.099854
| 137
| 7.549805
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.317871
| 1,775
| 0
|
34.99799
|
female
| 0
| 15
|
Coma
|
Coma
| 0
| 18
|
>$50k
| 44
| 8,265
| 36,901.7812
| null | 12.666664
|
white
| 20.398438
| 14
| 0.764893
| 0.720947
| 4
| 0
| 0
|
no
| 0.5
| 0.2
|
no dnr
| 15
| 103
| 10.099609
| 115
| 20
| 37.39844
| 330
| null | null | 0.699951
| 134
| 7.479492
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 455
| 1
|
65.96295
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 4
| null | 0
| 181,645
| 100,455.625
| null | 21.75
|
hispanic
| 21.5
| 21
| 0.824951
| 0.765991
| 2
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 55
| 80
| 15.099609
| 120
| 30
| 39
| 340
| 3.099609
| 0.699951
| 0.899902
| 142
| 7.5
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.097168
| 1,760
| 1
|
43.85999
|
female
| 0
| 43
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 186,293
| 104,734
| null | 17.25
|
hispanic
| 37.898438
| 63
| 0.539917
| 0.340942
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 43
| 46
| 3.5
| 80
| 20
| 37.19531
| 300
| 2.399902
| 38.398438
| 1.899902
| 138
| 7.469727
| null | null | null | 7
| 3
| null | 3
| 1,773
| 0
|
29.769
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 181,539
| 97,215.5625
| null | 30.5
|
asian
| 26
| 34
| 0.859985
| 0.810913
| 4
| 0
| 0
|
no
| null | null |
no dnr
| 34
| 110
| 16
| 120
| 30
| 37.69531
| 397.5
| 2
| 4.299805
| 0.699951
| 135
| 7.459961
| null | null | null | null | null | null | 2.126465
| 1,772
| 0
|
52.71997
|
female
| 1
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 20
|
$11-$25k
| 26
| 45,273
| 24,780.7969
| null | 23.5
|
white
| 20.699219
| 40
| 0.689941
| 0.523926
| 7
| 0
| 0
|
no
| 0.01
| 0.000001
|
dnr after sadm
| 4
| 97
| 9.5
| 75
| 18
| 36.39844
| 290.4375
| null | 2
| 2.5
| 137
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.087891
| 9
| 1
|
26.24799
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 100
| 260,829
| 118,488.25
| null | 40
|
white
| 54.5
| 117
| 0
| 0
| 47
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 35
| 0.049995
| 40
| 52
| 36.69531
| 206
| 1.699951
| 3.799805
| 1.899902
| 138
| 7.219727
| null | null | null | null | null |
<2 mo. follow-up
| 3.091797
| 4
| 1
|
66.75397
|
male
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 306,038
| 165,393.375
| null | 33.5
|
white
| 28.5
| 37
| 0.659912
| 0.562988
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 46
| 67
| 24.097656
| 120
| 22
| 37
| 106.65625
| null | null | 1.299805
| 139
| 7.509766
| null | null | null | null | null | null | 2.439941
| 69
| 1
|
53.125
|
male
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 8
|
$11-$25k
| 0
| 13,872
| 7,457.1602
| null | 5.666664
|
white
| 13.298828
| 13
| 0.796997
| 0.56897
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 14
| 70
| 9.199219
| 72
| 18
| 36.79688
| 376.1875
| null | 0.199982
| 1
| 136
| 7.459961
| null | null | null | 0
| null | null | 0.4948
| 139
| 1
|
70.74097
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
|
>$50k
| 0
| 72,222
| 38,194.5
| null | 37.666657
|
white
| 27.398438
| 49
| 0.603882
| 0.496948
| 6
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 14
| 77
| 23
| 115
| 28
| 39
| 120.40625
| 2.799805
| 0.099991
| 1.199951
| 135
| 7.5
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.428223
| 117
| 1
|
54.67798
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 38,322
| 22,746.25
| null | 17.5
|
white
| 24.898438
| 40
| 0.80188
| 0.680908
| 6
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 58
| null | 65
| 18
| 36.09375
| null | 2.5
| 1.799805
| 1.299805
| 145
| 7.5
| null | null | null | 3
| null |
<2 mo. follow-up
| 2.511099
| 37
| 1
|
81.45398
|
male
| 0
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 92,518
| 46,889.4062
| null | 21.75
|
white
| 16.398438
| 42
| 0.823975
| 0.764893
| 5
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 30
| 60
| 8.398438
| 75
| 40
| 38.89844
| 391
| 3
| null | 1.099854
| 132
| 7.529297
| null | null | null | null | null | null | 2.491211
| 163
| 1
|
58.27499
|
female
| 0
| 40
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 161,257
| 74,216.125
| null | 25.25
|
black
| 30.296875
| 30
| 0.766968
| 0.628906
| 1
| 0
| 0
|
no
| 0.2
| 0.15
|
no dnr
| 40
| 77
| 16.597656
| 115
| 12
| 37.29688
| 68
| 3.399902
| null | 0.899902
| 144
| 7.299805
| null | null | null | null | 6
| null | 6
| 607
| 1
|
36.96899
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 9
| 85,027
| 46,872.9375
| null | 37
|
other
| 48.59375
| 73
| 0.228973
| 0.128998
| 22
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 111
| 21.699219
| 120
| 70
| 39.89844
| null | 4.5
| 54.296875
| 5.699219
| 138
| null | null | null | null | null | null |
<2 mo. follow-up
| 2.412109
| 5
| 1
|
44.47897
|
male
| 0
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$25-$50k
| 0
| 12,696
| 8,186.1445
| null | 5
|
white
| 21.5
| 35
| 0.846924
| 0.747925
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 8
| 100
| 4.699219
| 82
| 18
| 36.79688
| null | 2.299805
| 14.199219
| 0.799927
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,767
| 0
|
79.98096
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 42,514
| 27,452.6562
| null | 16
|
white
| 1.899902
| 20
| 0.932983
| 0.841919
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 13
| 115
| 4.199219
| 70
| 22
| 38.39844
| null | 3.099609
| 1.599854
| 1
| 142
| null | null | null | null | null | 0
| null | 0
| 1,768
| 0
|
82.245
|
female
| 1
| 10
|
Coma
|
Coma
| 0
| null | null | 61
| 73,656
| 39,791
| null | 34
|
white
| 13.699219
| 19
| 0.468994
| 0.395996
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 123
| null | 75
| 9
| 36.69531
| 295
| null | null | 1.199951
| 140
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.355957
| 10
| 1
|
38.49698
|
male
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 17
|
>$50k
| 26
| 463,001
| 269,057
| null | 26.5
|
white
| 26.898438
| 35
| 0.736938
| 0.654907
| 8
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 62
| 73
| 10.099609
| 130
| 18
| 38.59375
| 237.5
| 3.099609
| 13.798828
| 1.099854
| 145
| 7.529297
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,766
| 0
|
59.37598
|
male
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 64,372
| 33,652.5
| null | 20
|
black
| 28
| 53
| 0.593994
| 0.484985
| 2
| 1
| 0
|
yes
| 0.5
| 0.3
|
no dnr
| 19
| 70
| 0.699951
| 120
| 32
| 37
| 396.625
| 2.099609
| 0.699951
| 0.899902
| 138
| 7.419922
| null | null | null | 0
| 0
| null | 0
| 110
| 1
|
58.44998
|
male
| 0
| 20
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 20
|
under $11k
| 0
| 30,148
| 18,298.875
| null | 7
|
white
| 19.296875
| 29
| 0.885986
| 0.80896
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 20
| 85
| 6.199219
| 90
| 28
| 37
| 403.3125
| null | null | 1.699951
| 133
| 7.5
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 33
| 1
|
83.30194
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
under $11k
| 37
| 49,455
| 23,976.9219
| null | 23.5
|
white
| 16.097656
| 42
| 0.7229
| 0.637939
| 4
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 9
| 130
| 11.898438
| 80
| 10
| 38.5
| 242.84375
| null | null | 1
| 138
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 3.564453
| 10
| 1
|
43.995
|
female
| 0
| 50
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 26
| 260,514
| 173,060.625
| null | 23.5
|
white
| 27.5
| 33
| 0.599976
| 0.41095
| 9
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 50
| 80
| 20.898438
| 130
| 20
| 36.29688
| 485
| 2.799805
| 3
| 1.899902
| 136
| 7.459961
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,760
| 0
|
50.09698
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 29,840
| 16,369.5781
| null | 14.333328
|
other
| 15.099609
| 5
| 0.850952
| 0.799927
| 1
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 15
| 97
| 11.099609
| 80
| 16
| 37.39844
| 419
| null | 0.699951
| 1.199951
| 136
| 7.449219
| null | null | null | 0
| 1
| null | 1
| 376
| 1
|
80.18896
|
male
| 1
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 19
|
>$50k
| 0
| 257,589
| 125,511.5
| null | 25
|
white
| 22.597656
| 37
| 0.737915
| 0.656982
| 4
| 0
| 0
|
no
| 0.4
| 0.2
|
dnr after sadm
| 39
| 133
| 10.199219
| 120
| 36
| 38.69531
| 204.4375
| null | 0.5
| 1.099854
| 147
| 7.469727
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 40
| 1
|
40.20499
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 151,181
| 74,438.9375
| null | 47
|
white
| 40.5
| 77
| 0.173981
| 0.088989
| 28
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 5
| 52
| 6.5
| 150
| 35
| 36.79688
| 122
| 2.699707
| 10.599609
| 1.199951
| 143
| 7.349609
| null | null | null | null | null |
<2 mo. follow-up
| 3.010742
| 6
| 1
|
57.01797
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 12,504
| 7,491.3047
| null | 9
|
white
| 9.599609
| 13
| 0.947998
| 0.910889
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 93
| 12.199219
| 88
| 18
| 37.19531
| 423.75
| 4.699219
| 0.599976
| 0.899902
| 133
| 7.419922
| null | null | null | null | null | null | 2.463379
| 1,462
| 1
|
38.90799
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 13
| null | 0
| 48,336
| 23,679.7969
| null | 19.5
|
white
| 34.398438
| 49
| 0.7229
| 0.637939
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 12
| 107
| 18.699219
| 120
| 28
| 37.5
| 280
| null | null | 4.299805
| 125
| 7.289062
| null | null | null | null | 3
| null | 3
| 1,480
| 1
|
75.54297
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 14
|
$25-$50k
| 0
| 18,233
| 11,379.5781
| null | 11.5
|
white
| 16.796875
| 11
| 0.79895
| 0.573975
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.8
|
no dnr
| 11
| 93
| 13.898438
| 84
| 20
| 36.19531
| null | null | 1.199951
| 1
| 136
| null | null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 484
| 1
|
34.80899
|
female
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 26
| 71,315
| 32,862.0938
| null | 41
|
white
| 46.796875
| 76
| 0.026997
| 0.007
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 5
| 62
| 0.699951
| 135
| 60
| 38.5
| 82
| 2.599609
| 6.099609
| 0.5
| 141
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.083496
| 9
| 1
|
73.72998
|
male
| 0
| 15
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 41,836
| 24,937.7812
| null | 11.333328
|
white
| 5.699219
| 20
| 0.914917
| 0.80188
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 15
| 127
| 5.299805
| 88
| 18
| 36.79688
| null | 4.299805
| 1.699951
| 1.099854
| 141
| null | null | null | null | null | null | null | 2.167481
| 879
| 1
|
42.543
|
male
| 1
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 26
| 217,970
| 106,592.312
| null | 31
|
white
| 39.5
| 65
| 0.195984
| 0.103989
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 8
| 50
| 1.099854
| 140
| 30
| 38.5
| 396.625
| null | null | 6.699219
| 137
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 2.62793
| 12
| 1
|
68.70099
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 8,570
| 4,938.3711
| null | 11
|
white
| 14.398438
| 20
| 0.747925
| 0.487
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 121
| 4.199219
| 74
| 8
| 37.79688
| null | null | null | 1
| 137
| null | null | null | null | null | null | null | 2.243652
| 100
| 1
|
73.56299
|
male
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 192,983
| 104,663.5
| null | 25
|
white
| 35.695313
| 62
| 0.199982
| 0.106995
| 10
| 0
| 0
|
yes
| 0.2
| 0.008
|
dnr after sadm
| 20
| 133
| 28.597656
| 140
| 39
| 38.89844
| 61
| null | null | 0.799927
| 132
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.908203
| 21
| 1
|
69.10297
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 39,080
| 21,387.7969
| null | 21
|
white
| 12.5
| 29
| 0.863892
| 0.695923
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 12
| 97
| 10.699219
| 115
| 28
| 37.29688
| null | 3
| 3.899902
| 0.899902
| 145
| null | null | null | null | null | null | null | 2.443848
| 1,479
| 1
|
67.41095
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| null | null | 100
| 19,247
| 10,152.1172
| null | 32
|
white
| 50.695313
| 73
| 0
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 35
| 13
| 140
| 10
| 41
| 171.40625
| null | null | 4.299805
| 151
| 7.509766
| null | null | null | null | null |
<2 mo. follow-up
| 2.92334
| 4
| 1
|
79.72095
|
male
| 1
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 18
|
>$50k
| 0
| 23,327
| 12,108.2656
| null | 24
|
asian
| 47.59375
| 54
| 0.144989
| 0.033997
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 33
| 8.099609
| 100
| 16
| 36.19531
| null | 2.899902
| null | 5.5
| 129
| null | null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 7
| 1
|
48.35898
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 60,676
| 31,216.8438
| null | 36.5
|
hispanic
| 34.296875
| 22
| 0.654907
| 0.555908
| 4
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 87
| 3.699707
| 125
| 17
| 36.59375
| 90.65625
| null | null | 0.599976
| 143
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
60.67398
|
male
| 1
| 94
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 481,475
| 247,740.75
| null | 31
|
white
| 35.796875
| 59
| 0.571899
| 0.377991
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 72
| 77
| 9.298828
| 100
| 36
| 36.59375
| 127.5
| null | null | 2.599609
| 125
| 7.529297
| null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 94
| 1
|
58.31897
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 5,877
| 3,397.6699
| null | 7
|
hispanic
| 16.898438
| 21
| 0.840942
| 0.738892
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 87
| 4.899414
| 80
| 20
| 37.19531
| null | 2.199707
| 4.799805
| 1
| 135
| null | null | null | null | null | null | null | 3.124512
| 562
| 1
|
59.88498
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$25-$50k
| 0
| 25,441
| 15,499.7812
| null | 19
|
white
| 13.898438
| 24
| 0.921997
| 0.86792
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 67
| 9.298828
| 110
| 18
| 36.79688
| null | 4.199219
| 0.399963
| 1.399902
| 140
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,742
| 0
|
64.02698
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 0
| 11,926
| 6,952.0156
| null | 12
|
white
| 8.099609
| 22
| 0.945923
| 0.907959
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 62
| 5.399414
| 70
| 18
| 36.5
| 252.375
| 4.599609
| 1.199951
| 1.099854
| 136
| 7.429688
| null | null | null | null | null | null | 1.665527
| 285
| 1
|
34.461
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 193,371
| 93,435.3125
| null | 33
|
white
| 57.398438
| 70
| 0.001
| 0
| 35
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 3
| 33
| 1.099854
| 130
| 35
| 35.89844
| 80
| 2.5
| 0.899902
| 1.299805
| 141
| 7.369141
| null | null | null | null | null |
<2 mo. follow-up
| 1.951172
| 3
| 1
|
47.33499
|
female
| 0
| 26
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 53,037
| 29,296.4375
| null | 13
|
white
| 16.199219
| 18
| 0.855957
| 0.680908
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 26
| 93
| 10
| 100
| 20
| 38.59375
| null | 4
| 6.199219
| 0.699951
| 140
| null | null | null | null | null | null | null | 2.608398
| 1,740
| 0
|
47.77798
|
female
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 14,867
| null | null | 5.5
|
other
| 19.199219
| 30
| 0.858887
| 0.766968
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 91
| 5.599609
| 76
| 20
| 37
| null | 1.899902
| 5.299805
| 0.699951
| 134
| null | null | null | null | null | null | null | 2.130371
| 1,739
| 0
|
49.28998
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| 73,143
| 38,012.75
| null | 60
|
white
| 57.5
| 103
| 0.090988
| 0.035995
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 6
| 47
| 2.399902
| 160
| 40
| 34
| 85
| null | null | 3
| 139
| 7.069336
| null | null | null | null | null |
<2 mo. follow-up
| 2.186035
| 6
| 1
|
51.573
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 121,630
| 59,514.5625
| null | 35.666657
|
white
| 29.699219
| 32
| 0.537964
| 0.42395
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 22
| 98
| 10.099609
| 85
| 28
| 37.19531
| 44.4375
| 3.399902
| 1.899902
| 1.299805
| 133
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.379883
| 24
| 1
|
73.90295
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 6,676
| 4,164.0781
| null | 11
|
white
| 19.199219
| 22
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 100
| 14.898438
| 100
| 20
| 36.79688
| null | null | null | 1.5
| 137
| null | null | null | null | null | null | null | 2.252441
| 1,736
| 0
|
71.28497
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 16,142
| 10,552.0469
| null | 7
|
white
| 16
| 17
| 0.713989
| 0.432983
| 1
| 1
| 0
|
metastatic
| 1
| 0.95
|
no dnr
| 7
| 95
| 16
| 70
| 22
| 37.5
| 495.1875
| null | null | 1.399902
| 137
| 7.40918
| null | null | null | null | null | null | 2.53418
| 1,736
| 0
|
55.29898
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 85,170
| 43,481.7812
| null | 23
|
white
| 21.898438
| 31
| 0.825928
| 0.767944
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 83
| 8.099609
| 150
| 32
| 38.69531
| 350
| null | null | 0.899902
| 130
| 7.489258
| null | null | null | null | null | null | 2.897461
| 1,735
| 0
|
52.68997
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 26
| 50,315
| 27,577.9062
| null | 13
|
white
| 22.699219
| 28
| 0.496948
| 0.378967
| 6
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 125
| 15.599609
| 118
| 36
| 37
| 310
| null | null | 0.899902
| 141
| 7.469727
| null | null | null | null | null | null | 3.729004
| 353
| 1
|
81.38794
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 207,883
| 108,700.562
| null | 42.5
|
white
| 26.296875
| 58
| 0.483948
| 0.365967
| 21
| 0
| 0
|
no
| null | null |
dnr after sadm
| 9
| 63
| 17.5
| 70
| 37
| 39
| 285
| 2.199707
| 3.199707
| 4.199219
| 138
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 3.170898
| 9
| 1
|
49.29999
|
male
| 0
| 29
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 241,565
| 129,540.125
| null | 27.5
|
white
| 32.898438
| 54
| 0.591919
| 0.40094
| 2
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 29
| 87
| 5.799805
| 110
| 16
| 35.19531
| 194.28125
| 2.199707
| 4
| 3.099609
| 148
| 7.439453
| null | null | null | null | null | null | 3.924316
| 160
| 1
|
64.69299
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 26
| 24,410
| 13,153.6484
| null | 14
|
white
| 7.199219
| 21
| 0.876953
| 0.721924
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.75
|
no dnr
| 9
| 67
| 9.898438
| 110
| 12
| 37.5
| 215
| 4.5
| 0.799927
| 1.099854
| 135
| 7.449219
| null | null | null | 0
| null | null | 0.4948
| 523
| 1
|
61.67798
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 18,565
| 11,830.1406
| null | 9.5
|
white
| 15.298828
| 16
| 0.843994
| 0.655884
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 9
| 95
| 11.798828
| 88
| 20
| 37
| null | null | 0.599976
| 1.299805
| 139
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 2.569336
| 926
| 1
|
64.25195
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
| null | 0
| 7,339
| 4,110.2852
| null | 6
|
white
| 20
| 32
| 0.863892
| 0.773926
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 73
| 3.899902
| 110
| 24
| 36.39844
| 256.625
| null | null | 1.5
| 136
| 7.339844
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.195801
| 1,049
| 1
|
56.95798
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 80,188
| 43,882.9062
| null | 37.5
|
other
| 42.09375
| 59
| 0.227997
| 0.128998
| 7
| 0
| 0
|
no
| null | null |
dnr after sadm
| 7
| 68
| 17.5
| 125
| 32
| 36.39844
| 193.875
| null | 35
| 9.099609
| 146
| 7.479492
| null | null | null | null | null |
<2 mo. follow-up
| 2.54541
| 7
| 1
|
29.71399
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 55,429
| 31,358.9688
| null | 38
|
other
| 31.097656
| 30
| 0.563965
| 0.452942
| 2
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 7
| 120
| 2.699707
| 55
| 14
| 36.09375
| 190
| null | null | 1.5
| 128
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.369141
| 7
| 1
|
35.56998
|
female
| 0
| 33
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 19
|
>$50k
| 0
| 141,926
| 69,217.8125
| null | 21
|
black
| 31.199219
| 46
| 0.491943
| 0.373962
| 8
| 0
| 0
|
yes
| null | null |
no dnr
| 33
| 113
| 0.049995
| 120
| 28
| 37.59375
| 419
| 2.5
| 1.099854
| 0.699951
| 133
| 7.459961
| null | null | null | 5
| 6
| null | 6
| 66
| 1
|
38.42297
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 36,468
| 21,043.3125
| null | 10
|
black
| 22.199219
| 38
| 0.886963
| 0.846924
| 2
| 1
| 0
|
no
| null | null |
no dnr
| 10
| 114
| 21
| 98
| 20
| 38
| null | null | null | 10.5
| 131
| null | null | null | null | null | null | null | 3.471191
| 520
| 1
|
62.53497
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 41
| 188,728
| 91,829.375
| null | 29.666656
|
white
| 30.5
| 29
| 0.419983
| 0.300964
| 17
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 1
| 88
| 3.699707
| 130
| 24
| 39.5
| 140
| null | null | 1.199951
| 148
| 7.5
| null | null | null | null | null | null | 2.736328
| 149
| 1
|
76.49597
|
male
| 1
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 26
| 7,422
| 4,047.9668
| null | 11
|
white
| 22.5
| 51
| 0.416992
| 0.113998
| 1
| 0
| 0
|
metastatic
| 0.2
| 0.1
|
dnr after sadm
| 2
| 110
| 13.898438
| 72
| 26
| 36.19531
| 209.0625
| null | 0.399963
| 2
| 146
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.186035
| 5
| 1
|
83.16199
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| null | null | 89
| 13,767
| 7,227.2383
| null | 25
|
white
| 21.898438
| 29
| 0.148987
| 0.097992
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 93
| 18
| 150
| 32
| 37.89844
| 593
| null | null | 1.199951
| 136
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 3.277344
| 3
| 1
|
57.52798
|
male
| 0
| 20
|
Coma
|
Coma
| 0
| null | null | 94
| 82,244
| 39,760.5938
| null | 25.333328
|
white
| 16.5
| 19
| 0.529907
| 0.459961
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 20
| 60
| 19.796875
| 75
| 15
| 36.89844
| 210
| null | null | 1
| 137
| 7.469727
| null | null | null | null | null | null | 2.398926
| 1,722
| 0
|
73.66498
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 9,640
| 6,026.8203
| null | 7
|
white
| 17.199219
| 22
| 0.797974
| 0.571899
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
dnr after sadm
| 1
| 93
| 3.5
| 84
| 20
| 36.39844
| null | null | null | 1.5
| 133
| null | null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 31
| 1
|
46.51099
|
male
| 0
| 74
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 15
|
$25-$50k
| 100
| 603,388
| 324,555
| null | 42
|
black
| 38.296875
| 83
| 0.054993
| 0.006
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 74
| 67
| 17.597656
| 110
| 36
| 39
| 420
| 1.5
| 31.597656
| 5.5
| 137
| 7.629883
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 1,717
| 0
|
78.91895
|
female
| 1
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 55
| 219,537
| 104,714.062
| null | 35
|
white
| 22.199219
| 43
| 0.56189
| 0.449951
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 28
| 60
| 27.597656
| 100
| 18
| 38.5
| 282.8125
| 2.699707
| null | 2.599609
| 140
| 7.359375
| null | null | null | null | null |
<2 mo. follow-up
| 3.28418
| 37
| 1
|
68.91394
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 30,869
| 17,227.4375
| null | 15
|
white
| 25.199219
| 28
| 0.774902
| 0.701904
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 67
| 16.097656
| 135
| 32
| 37.19531
| 222.84375
| 3.099609
| 0.599976
| 0.5
| 135
| 7.5
| null | null | null | null | null | null | 2.762207
| 253
| 1
|
42.29199
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 161,776
| 84,674.25
| null | 53
|
white
| 57.59375
| 77
| 0.001
| 0
| 36
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 4
| 42
| 14.298828
| 115
| 35
| 38.39844
| 32
| null | 1.699951
| 3.5
| 125
| 7.25
| null | null | null | null | null |
<2 mo. follow-up
| 2.140137
| 5
| 1
|
46.57898
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 22
|
under $11k
| 0
| 17,254
| 10,264.8203
| null | 12
|
black
| 19.398438
| 23
| 0.909912
| 0.848999
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 72
| 6.299805
| 100
| 20
| 36.19531
| null | null | null | 1.599854
| 136
| null | null | null | null | 0
| null | null | 0.4948
| 316
| 1
|
54.03998
|
male
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 135,849
| 92,919.4375
| null | 22.666656
|
white
| 25.597656
| 26
| 0.830933
| 0.724976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 68
| 5.299805
| 110
| 12
| 36.09375
| 353.3125
| 3.099609
| 1.799805
| 1.199951
| 129
| 7.529297
| null | null | null | 0
| 1
| null | 1
| 1,712
| 0
|
45.10599
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 35,204
| 18,938.3125
| null | 19.5
|
white
| 25.699219
| 33
| 0.845947
| 0.792969
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 92
| 8
| 120
| 36
| 37.09375
| 142.84375
| 2.899902
| null | 1.299805
| 134
| 7.5
| null | null | null | null | null | null | 2.760254
| 1,711
| 0
|
87.46295
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| null |
>$50k
| 0
| 12,163
| 7,719.5469
| null | 6.5
|
white
| 20.398438
| 21
| 0.775879
| 0.642944
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 10
| 93
| 8.398438
| 84
| 20
| 36.39844
| 342.8125
| null | null | 0.799927
| 126
| 7.489258
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.779297
| 1,503
| 1
|
79.24695
|
female
| 1
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 26
| 174,898
| 83,313.125
| null | 32.5
|
black
| 26.699219
| 51
| 0.55896
| 0.445984
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 18
| 73
| 10.599609
| 110
| 25
| 37.59375
| 115
| 2.099609
| null | 1.099854
| 135
| 7.5
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 34
| 1
|
39.73999
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 26
| 352,017
| 237,611.75
| null | 50
|
other
| 38.195313
| 75
| 0.441956
| 0.32196
| 12
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 60
| 20.597656
| 130
| 44
| 39.29688
| 238
| 3.299805
| 11.099609
| 4.599609
| 146
| 7.429688
| null | null | null | null | null |
<2 mo. follow-up
| 3.224121
| 4
| 1
|
78.17395
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 41
| 372,459
| 185,530.625
| null | 45
|
asian
| 47.695313
| 82
| 0.007
| 0.001
| 48
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 45
| 10.5
| 120
| 28
| 36.89844
| 317.5
| 5.799805
| 23.199219
| 2.299805
| 131
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.979492
| 7
| 1
|
79.13196
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 9
| 36,811
| 19,305.6875
| null | 19
|
white
| 32.296875
| 39
| 0.362
| 0.243988
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 13
| 47
| 18.199219
| 90
| 22
| 37.19531
| 100
| null | 0.699951
| 0.899902
| 136
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 4.635742
| 18
| 1
|
70.63898
|
male
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 0
| 104,045
| 60,743.4688
| null | 14.5
|
white
| 27.597656
| 32
| 0.647949
| 0.547974
| 12
| 0
| 0
|
no
| 0.15
| 0.003375
|
no dnr
| 32
| 80
| 11.298828
| 95
| 18
| 37
| 148.3125
| 4.199219
| 0.699951
| 5.799805
| 139
| 7.229492
| null | null | null | 0
| null | null | 0.4948
| 376
| 1
|
41.26498
|
female
| 1
| 118
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 55
| 597,427
| 312,839.5
| null | 40
|
white
| 48
| 87
| 0.123993
| 0.054993
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 118
| 53
| 8.099609
| 129
| 26
| 36.5
| 92
| 4
| 11.699219
| 4.199219
| 151
| 7.319336
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.331543
| 118
| 1
|
38.35699
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 5,573
| 3,331.4453
| null | 12
|
white
| 19.199219
| 11
| 0.835938
| 0.640991
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 71
| 8.398438
| 80
| 16
| 36.79688
| null | 3
| 0.5
| 0.799927
| 139
| null | null | null | null | null | null | null | 2.004395
| 303
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.